When you think of MDMA, you might imagine a dodgy drug deal or a sweaty dancefloor, but the illicit party-drug may become a legal medicine in just three years. US researchers are conducting final clinical trials testing MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD). Dr. Gillinder Bedi is a Senior Research Fellow at the University of Melbourne and Head of Substance Use Research, Orygen National Centre of Excellence in Youth Mental Health. Her new paper asks ‘Is psychiatry ready for medical MDMA?‘. Listen to her conversation on Thursday Drive below.